Table 1

Patient demographics

	CHX–IA (n=148)	PI (n=156)	p Value
Gestational age (weeks)*	27 (2)	27 (2)	0.558
Birth weight (g)*	1017 (289)	1014 (326)	0.92
Male†	81 (55)	69 (44)	0.067
Antenatal steroid exposure†	144 (97)	155 (99)	0.309
Caesarean section†	91 (61)	100 (64)	0.891
Clinical chorioamnionitis†	14 (9)	24 (15)	0.082
Multiple birth†	62 (42)	54 (35)	0.509
Apgar score at 1 min*	6 (2)	6 (2)	0.537
Apgar score at 5 min*	8 (2)	8 (2)	0.364
Ventilation prerandomisation†	64 (43)	78 (50)	0.143
CPAP prerandomisation†	102 (69)	100 (64)	0.221
UVC as first CVC†	96 (65)	104 (67)	0.809
Day of life randomised‡ UVC first inserted (CHX 96, PI 104) PICC first inserted (CHX–IA 52, PI 52)	0 (0, 1) 0 (0, 0) 1 (0, 1)	0 (0, 0) 0 (0, 0) 1 (0, 1)	0.438
Total CVCs	384	431	0.328
Total CVC days	1465	1613	0.400
No of CVCs per patient†	3 (1)	3 (1)	0.121
Duration CVC in situ per patient (days)‡	9 (6, 12)	9 (6, 13)	0.553

Data are * mean (SD), †n (%), and ‡ median (IQR).
CHX–IA, 2% chlorhexidine–70% isopropyl alcohol; CPAP, continuous positive airway pressure; CVC, central venous catheter; PI, 10% aqueous povidone-iodine; UVC, umbilical venous catheter.